European Commission

  • Chances of Brexit deal fading every day, EU Commission chief says
    BRUSSELS/LONDON, September 16 (Reuters): The head of the European Commission said on Wednesday the chances of reaching a trade deal with Britain were fading by the day as the British government pushes ahead with moves that would breach their divorce treaty. The British government unveiled draft legislation last week which it acknowledges would violate its international legal obligations and undercut parts of the divorce deal it signed before Britain formally left the European U
  • European Commission to propose more ambitious 2030 climate goal: document
    BRUSSELS, September 11 (Reuters): The European Commission will propose that the European Union sets a 2030 target of cutting its net greenhouse gas emissions by at least 55% against 1990 levels, according to an internal document seen by Reuters. Already well on the way to meeting its current climate target of a 40% cut by 2030, the EU wants to set a more ambitious near-term target in order to achieve its goal of net zero emissions by 2050 and cement its status as a global leade
  • EU pays 336 million euros to secure AstraZeneca's potential COVID-19 vaccine
    BRUSSELS, August 27 (Reuters): The European Commission has made a 336 million euros ($396 million) downpayment to British drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-19 vaccine, a spokesman said on Thursday. The deal covers development, liability and other costs faced by the vaccine maker. The EU has also secured an option to buy 100 million additional doses of the vaccine under development. The 27 EU states could buy it at a later stag
  • Fearing autumn COVID wave, EU urges earlier, broader flu vaccination
    BRUSSELS, July 15 (Reuters): The European Commission said on Wednesday European Union states should launch earlier and broader vaccination campaigns against flu this year to reduce the risk of simultaneous influenza and COVID-19 outbreaks in the autumn.   The EU executive wants to prevent the risk of hospitals being again overwhelmed by a surge of patients, as happened at the peak of the COVID-19 pandemic in Europe in March and April.   "Simultaneou
  • EU reaches deals with Roche, Merck for supply of COVID-19 drugs - source
    BRUSSELS, July 8 (Reuters): The European Commission has reached agreements with pharmaceutical companies Roche and Merck KGaA  to supply experimental drugs that can be used to treat COVID-19 patients, a commission source told Reuters on Wednesday.   The EU executive agreed to the deal to source Roche's RoActemra and Merck's Rebif for supply to any 27 EU members states willing to buy them, the source who is familiar with the issue told Reuters. The pers
  • Coronavirus is not high threat to workers, EU says, causing outcry
    BRUSSELS, June 3 (Reuters): The European Commission classified the new coronavirus as a mid-level threat to workers, drawing criticism from socialist lawmakers because the move will allow less stringent workplace safety measures than if the virus was deemed a high risk.   The decision has wide economic and health implications as it could affect companies' costs in restarting business activity and have an impact on workers' safety.   The Commission, th